The Influence of Sedation for Endoscopy on Cognitive Function

Status Terminated

Clinical Trial Summary

It is commonly recommended that patients should refrain from driving for 24 hours after sedation for endoscopy，however，this recommendation has been queried recently．To investigate the effect of sedation on early postoperative cognitive function in patients undergoing endoscopy.

Clinical Trial Description

One hundred adult patients undergoing sedative esophagogastroduodenoscopy ( EGD) were randomly recruited，and another 100 adult patients undergoing conventional（without sedation） EGD were served as controls． All patients had an education level more than 9 years． Cognitive function was assessed by Montreal Cognitive Assessment（MoCA）1 week before EGD exam, 10 mins before propofol sedation or the beginning of endoscopic procedure, 30mins after EGD exam, and 2 week after exam. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04168294
Study type	Observational
Source	Shanghai Jiao Tong University School of Medicine
Contact
Status	Terminated
Phase
Start date	November 14, 2019
Completion date	November 14, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02488720` - Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Recruiting	`NCT03544801` - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting	`NCT02813434` - Cerebral Amyloid Imaging Using Florbetapir (AV-45)	Phase 3
Completed	`NCT00400790` - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane	N/A
Completed	`NCT00052091` - Therapy for Depressed Elders With Thought Problems	Phase 3
Completed	`NCT00021866` - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy	N/A
Completed	`NCT00267163` - Brain Imaging and Mental Disorders of Aging Intervention	Phase 4
Not yet recruiting	`NCT04079075` - Multiple Interventions to Prevent Cognitive Decline	N/A
Terminated	`NCT03696082` - A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines	N/A
Completed	`NCT02918539` - Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Active, not recruiting	`NCT01708837` - Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction	Phase 4
Completed	`NCT01290939` - Bevacizumab and Lomustine for Recurrent GBM	Phase 3
Terminated	`NCT00548327` - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype	Phase 2
Unknown status	`NCT00256425` - Cognitive Rehabilitation of Glioma Patients	Phase 3
Recruiting	`NCT03926351` - High Dose Omega 3 in People at Risk for Dementia	Phase 2
Completed	`NCT02118571` - Schizophrenia Cognition Scale Development	N/A
Completed	`NCT01481961` - Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease	N/A
Completed	`NCT00788918` - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)	N/A
Completed	`NCT00564902` - The Zeaxanthin and Visual Function Study	N/A
Completed	`NCT00529581` - A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis	Phase 2